The reform of the EU’s pharmaceutical legislation will not be adopted ahead of June’s European elections, an MEP involved in the negotiations in parliament has acknowledged. As things stand, the two proposed revisions of the text are diametrically opposed, meaning there are awkward negotiations ahead. With the clock running down, parliament’s objective now is to reach agreement and vote on the text in the final plenary of this term in April.